iPhone Competition
advanced search

Welcome: Guest

log in

Dental Gingivitis or Periodontitis

Publication Date March 2008
Publisher Life Science Analytics
Product Type Report
Pages 74
ISBN Number not applicable
Product Code LSA02330
Price

£800.00
approximately: $1,605 | €1,004

PDF Buy Now
PRINT £850 ($1,705 | €1,067) Buy Now
Order above formats by FAX Order by FAX

Summary

Life Science Analytics', Central Nervous System Parkinson Disease contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics' Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.

Key benefits

  • Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
  • Keep track of your competitors and partners by better understanding their product pipeline.
  • Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
  • Maintain a critical competitive advantage.

Content

  • Recent Highlights and Changes
  • Upcoming Patent Expires by Therapy Area
    • Parkinson Disease Pipeline Overview
      • % of Projects (by Phase of Development)
      • No. of Projects by Phase of Development
      • Marketed Products vs. Pipeline Products
    • Company Overview - Pipeline Projects
      • Company Overview - Pipeline Projects
      • Top Companies in late stage Parkinson Disease Projects
      • axxonis Pharma AG.
      • erly NeuroBiotec Pharma AG)
      • Avicena Group Inc
      • Cell Genesys Inc
      • Britannia Pharmaceuticals Limited
      • Chiesi Farmaceutici S.p.A
      • Ceregene, Inc
      • Genzyme Corporation
      • Dainippon Sumitomo Pharma Co., Ltd.
      • Newron Pharmaceuticals SpA
      • Kyowa Hakko Kogyo Co., Ltd.
      • Oxford BioMedica plc
      • Otsuka Pharmaceutical Co., Ltd.
      • Prestwick Pharmaceuticals, Inc.
      • Oy Juvantia Pharma Ltd.
      • Schwarz Pharma Ag
      • Schering-Plough Corp
      • Teva Pharmaceutical Industries Ltd
      • Solvay S.A.
      • Vernalis Plc ADR
      • Vectura Group plc.
      • Top Companies in early stage Parkinson Disease Projects
      • Alseres Pharmaceuticals, Inc.
      • Addex Pharmaceuticals SA
      • AnGes MG, Inc.
      • Amarin Corporation plc
      • ExonHit Therapeutics SA
      • Evotec AG
      • Kyowa Hakko Kogyo Co., Ltd.
      • Intra-Cellular Therapies, Inc.
      • Merck & Co Inc
      • Laboratorios Almirall, S.A.
      • NeuroSearch A/S
      • NeuroNova AB
      • Penwest Pharmaceuticals Co
      • Panacea Pharmaceuticals, Inc.
      • Shionogi & Co., Ltd.
      • Proneuron Biotechnologies, Inc.
      • Sygnis Pharma AG
      • Spherics, Inc
      • Takeda Pharmaceutical Company Limited
      • Synosia Therapeutics
      • erly Synosis Therapeutics)
    • Pipeline Revenue
      • Pipeline Revenue
    • Full Pipeline View
      • Pre Clinical Pipeline View
      • Phase I Pipeline View
      • Phase II Pipeline View
      • Phase III Pipeline View
      • Pending Approval Pipeline View
      • Approved Pipeline View
      • on the Market Pipeline View
      • Discovery/Development Pipeline View